Askina® Transorbent®, Askina® Transorbent® Border, Askina® Transorbent® Sacrum

نویسنده

  • B. Braun
چکیده

1.PRODUCT DESCRIPTION Askina® Transorbent®, Askina® Transorbent® Border & Askina® Transorbent® Sacrum are multilayered semi-permeable dressings which consist of the following: • an adhesive layer that bonds to the intact skin, but is non-adherent to the wound • a dry hydrogel layer with high absorption capacity. • a foam layer that provides a degree of cushioning to the wound. • a vapour permeable, water and bacteria impermeable outer layer (which extends beyond the perimeter of the outer layers to form an adhesive border on Askina® Transorbent® Border & Askina® Transorbent® Sacrum) Askina® Transorbent®, Askina® Transorbent® Border & Askina® Transorbent® Sacrum maintain a moist environment to enhance the natural healing process. 2. INDICATIONS Askina® Transorbent®, Askina® Transorbent® Border & Askina® Transorbent® Sacrum are indicated for the management of moderately to heavily, partial thickness and full thickness wounds, such as stage I-IV pressure ulcers, arterial and venous stasis leg ulcers, neuropathic ulcers, and to aid in the prevention of skin breakdown. 3.CONTRAINDICATIONS Askina® Transorbent®, Askina® Transorbent® Border & Askina® Transorbent® Sacrum are contraindicated for ulcers resulting from • infection, such as tuberculosis, syphilis, or deep fungal infections, or • third degree burns. • In case of infection with inflammatory signs (temperature, oedema, redness) contact proper medical authority Resume use when normal healing conditions are present. 4.INFORMATION FOR USE 4.1. Skin preparation a) Cleanse the wound with an appropriate solution (e.g. Prontosan®) in accordance with normal procedures. b) Dry the surrounding skin. 4.2. Dressing application a) Select the appropriate size to cover the wound surface, ensure a 2 to 3 cm margin beyond the wound edge. b) Remove one of the backing liners and apply the adherent side to the wound. c) Smooth the dressing over the wound while removing the remaining backing liner. d) When applying to a contoured area (i.e. heel or elbow), slit the dressing approximately one-third across each side to ease application and encourage adhesion. When applying Askina® Transorbent® Sacrum to • a sacral ulcer, slightly flex the dressing and place into the gluteal fold. Smooth outward to ensure adhesion. • the anal region, one of the points of the dressing may be cut so that it can be placed as deep as necessary and still remains fixed in position. 4.3 Dressing changes The interval between dressing changes will depend entirely upon the state of the wound and the amount of exudate. Askina® Transorbent®, Askina® Transorbent® Border, & Askina® Transorbent® Sacrum should be changed when saturated with exudate : 2 to 3 days on average or every 24hrs when the amount of exudate is significant. Change immediately if leakage occurs. Use rinsing solution to facilitate removal when necessary. 5. SPECIAL NOTES The wound may initially appear to increase in size in the early stages of treatment. This is normal and occurs as any wound debris is removed from the edges of the wound. This clears the way for healing. There are cases where healing is impaired as a result of underlying conditions; in these instances, Askina® Transorbent®, Askina® Transorbent® Border, & Askina® Transorbent® Sacrum alone may make little or no progress, and suitable treatment of the underlying conditions will be necessary as well. If after 4-6 weeks of Askina® Transorbent®, Askina® Transorbent® Border, and Askina® Transorbent® Sacrum treatment, there has been no improvement, then, in line with accepted wound management practice, the original diagnosis and overall therapy should be reassessed. Sterile unless pack damaged or opened.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Extraction of Zn, Mn and Co from Zn-Mn-Co-Cd-Ni containing solution using D2EHPA, CYANEX® 272 and CYANEX® 302

Effects of pH, D2EHPA, Cyanex® 302 and Cyanex® 272 on extractions of zinc, manganese and cobalt from a Zn-Mn-Co-Cd-Ni containing solution was comprehensively investigated at the room temperature. The addition of Cyanex® 302 indicated a left-shifting-effect on the extraction curve of zinc, a right-shifting-effect on the extraction curve of manganese and no effect on the extraction of cobalt. The...

متن کامل

P-95: Flow Cytometry Analysis of Bovine Semen:A Qualitative Study

Background: Although AI practices have been introduced little over 60 years, the success rate remains relatively low. This might be due to the exclusive selection of semen based on motility analysis. Recent advancement in sperm sexing using flow cytometry with an increased throughput from next generation cell sorters, made use of this technology in studding sperm qualitative aspects other than ...

متن کامل

کنترل شیمیایی علف های هرز در ارزن دم روباهی (Setaria italica L.)

سابقه و هدف: گسترش پدیده خشکسالی و شوری در کشور و تحمل ارزن به شرایط خشک و شور سبب گسترش کشت ارزن شده است. علف‌های هرز یکی از مهمترین عوامل کاهش عملکرد ارزن هستند. بنابراین مدیریت مناسب علف‌های هرز باعث بهبود عملکرد محصول و افزایش کارآیی نهاده‌های مصرفی در آن می‌شود. کنترل شیمیایی علف‌های هرز از نظر سهولت در کاربرد و کاهش هزینه‌های کارگری همواره مورد توجه بوده است. از سوی دیگر تاکنون تحقیق جامع...

متن کامل

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial

Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH, high costs of enoxaparin branded preparations limit its use. We aimed to compare the efficacy and...

متن کامل

P-6: Effects of Green Biologic Rodenticide, Biorotox®, on Fertility of Male Rats

Background Biorotox® is an invented green biologic rodenticide. The present study was designed to determine whether this toxin could cause infertility in male rats. MaterialsAndMethods Sixteen Sprague-Dawley adult male rats were randomly divided into control and treatment groups. Treatment group was received diets containing Biorotox ® for 35 days. Control group was given standard rat food. Wei...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014